INFLUENCE OF VITAMIN D STATUS ON THE SEVERITY OF ANEMIA OF INFLAMMATION IN YOUNG CHILDREN WITH ACUTE INFLAMMATORY BACTERIAL RESPIRATORY DISEASES

Author(s):  
H. O. Lezhenko ◽  
A. O. Pogribna
2021 ◽  
Vol 16 (4) ◽  
pp. 289-295
Author(s):  
H.O. Lezhenko ◽  
A.O. Pogribna

Background. Randomization of pathogenetic factors that determine the risk of developing anemia of inflammation in young children with acute inflammatory bacterial diseases of the respiratory system, and the creation of a mathematical model for predicting its development were the purposes of the study. Materials and methods. The study groups included 80 children, the ave­rage age of the patients was 1.6 ± 0.3 years. The basic group consisted of 40 children with acute inflammatory bacterial respiratory diseases, which, taking into account the hematological picture, was divided into two subgroups: the first subgroup — 26 children with anemia of inflammation, which was determined 4–5 days after the onset of the disease; the second subgroup — 14 children without anemia. The comparison group enrolled 20 children with iron deficiency anemia without inflammatory manifestations. The control group consisted of 20 apparently healthy children. To identify the signs that are most associated with the development of anemia of inflammation, the method of factor analysis was used. The basis of modeling for the selection of factor complexes was the Spearman correlation matrix with the subsequent determination of the factor loading. The analysis of the prognostic significance of individual signs as risk factors for the development of anemia of inflammation in young children with acute inflammatory bacterial respiratory diseases was carried out based on calculating the relative risk (RR) index in 2 x 2 contingency tables with the determination of 95% confidence intervals (95% CI) and Pearson’s χ2 test. The most significant factors included informative signs with an RR value of more than 1.0. To predict the probability of developing anemia of inflammation, the method of binary logistic regression was used. Results. The factorial analysis results demonstrated five factors that have eigenvalues greater than 1.0 and describe 70.5 % of the total dispersion of the variables. Factor 1, the “factor of iron metabolism”, described 21.5 % of the total variance and included 2 variables: the number of red blood cells and the level of hepcidin. Factor 2, the “anemia factor”, described 14.6 % of the total dispersion and included hemoglobin levels. Factor 3, “oxidative stress factor”, described 12.7 % of the total dispersion and included 2 variables: nitrotyrosine content and IL-6 level. Factor 4, the “pro-inflammatory factor”, described 12.2 % of the total dispersion and included data on phospholipase A2 content and the severity of the inflammatory disease. Factor 5, “iron deposition factor”, described 8.9 % of the total dispersion and included ferritin level data. At the next stage, calculating the RR index, we identified five risk factors that have the greatest influence on the development of anemia of inflammation: ferritin content (≥ 73.2 ± 4.6 ng/ml), the presence of gram-negative microflora as a bacterial agent that caused the development of inflammatory diseases, the presence of febrile fever in the patient, repeated episode of inflammatory disease, hepcidin level (≥ 1.9 ± 0.11 ng/ml). Conclusions. Based on the results of the conducted factor analysis, a prognostic model was formed for the development of anemia of inflammation in young children with acute inflammatory bacterial respiratory diseases. According to the results of factor analysis, it was found that the leading contribution to the pathogenesis of the development of anemia of inflammation was made by disorders of iron metabolism against the background of the inflammatory process, including the processes of iron deposition; oxidative stress, and interleukin-6. It is advisable to use certain risk factors and the results of predictive modeling regarded to the group of high risk of developing anemia of inflammation in young children with acute inflammatory bacterial respiratory di­seases.


PLoS ONE ◽  
2015 ◽  
Vol 10 (10) ◽  
pp. e0141595 ◽  
Author(s):  
Xin Zhao ◽  
Jianping Xiao ◽  
Xiangpeng Liao ◽  
Liyi Cai ◽  
Fei Xu ◽  
...  

2021 ◽  
pp. 74-80
Author(s):  
O.H. Shadrin ◽  
◽  
H.A. Haiduchyk ◽  
M.H. Horianska ◽  
◽  
...  

Aim is to investigate vitamin D status in young children with gastrointestinal manifestations of food allergy. Materials and methods. 30 children aged 4 months to 3 years with enterocolitis syndrome induced by dietary proteins were examined. General clinical examination included assessment of physical and somatic status (body weight, height, sleep, appetite), condition of the skin and mucous membranes, skeletal system, internal organs, nature and frequency of bowel movements. To assess vitamin D status in children with gastrointestinal allergy, we used quantitative determination of the concentration of 25 (OH) D (25-hydroxycalciferol) in blood serum using the Architect 2000sr I «ABBOT» immunochemical assay (USA). Complex treatment of the underlying disease involved correction of vitamin D deficiency using the drug «Aquadetrim» containing aqueous solution of colecalciferol for oral administration at a dose of 2000 U/day for 1 month. The comparison group included 20 children aged 12–24 months with non$aggravated individual and family history of allergies, who had functional diseases of the gastrointestinal tract (functional constipation, functional diarrhea, flatulence syndrome) and did not take vitamin D preparations. The data of clinical and laboratory trials were processed by the methods of mathematical statistics adopted in biology and medicine. The reliability of differences in comparative indicators was determined using the Student's t-test and nominal data using Fisher's exact test. Results and conclusions. Based on the results of assessing the vitamin D status in young children with gastrointestinal food allergy by determining serum concentrations of 25-hydroxycalciferol, vitamin D deficiency was established in 86.7% of patients — with average of 26.39 (21.08–29.98) ng/ml. Administration of aqueous solution of colecalciferol (Aquadetrim) at a dose of 2000 IU per day for 1 month to children with gastrointestinal food allergy helped to normalize the concentration of 25-hydroxycalciferol in blood serum of 92.3% of children. Against the background of the use of the vitamin D preparation (Aquadetrim), there were no cases of deterioration of gastrointestinal and skin manifestations of the disease; «Akvadetrim» preparation was well tolerated, without side reactions. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of these Institutes. The informed consent of the patient was obtained for conducting the studies. No conflict of interest was declared by the authors. Key words: gastrointestinal manifestations of food allergy, young children, vitamin D.


ScienceRise ◽  
2020 ◽  
pp. 51-58
Author(s):  
Mariia Romanko ◽  
Zoia Rossokha ◽  
Iryna Maydan ◽  
Maryna Mamenko ◽  
Lyudmila Kvashnina

Object of the research: VDBP gene polymorphism. Problem being addressed: the effect of existing polymorphic variants of the VDBP gene on the absorption of vitamin D in young children. The main scientific results. At the beginning of the survey, vitamin D supplementation was performed in 50.0±9.1 % (15/30) of children. The concentration of 25 (OH) D in the serum of the subjects was 32.9 ng/ml (23.2–60.0). All patients with the GG rs 7041 genotype of the VDBP gene had a concentration of 25 (OH) D in the range of 20-100 ng/ml, which is statistically more common than in children with the AA rs 4588 genotype (p=0.015), GT rs 7041 genotype (p=0.047) and genotype TT rs 7041 (p=0.033). Patients with CA rs 4588 genotypes – 23.7 ng/ml (14.8-35.8) and GT rs 7041 – 28.1 ng/ml (17.1–49) had the lowest serum levels of 25 (OH) D, the highest levels of 25 (OH) D – children with genotype AA rs 4588 – 122.6 ng/ml (23.2–124.1) and genotype TT rs 7041 – 78.6 ng/ml (23.2 –124.1). Carriers of the AA rs 4588 genotype were more likely than patients with the GG rs 7041 genotype to show dangerously high levels of 25 (OH) D (p=0.069). Patients with the AA rs 4588 genotype had lower alkaline phosphatase levels compared to the GT rs 7041 and CC rs 4588 genotypes – 185.0 U/l (147.0–212.0) versus 259.5 U/l (207.0–334.5), p=0.021 and against 251.0 U/l (222.0–346.0), p=0.016. Area of practical application of research results: The results of the study can be used by working groups to make recommendations for the prevention and treatment of vitamin D deficiency and in the practice of health care facilities. Innovative technological product: association between allelic variants of the VDBP gene and vitamin D status in young children. Scope of application of innovative technological product: pediatrics, medical genetics. Conclusions. Genetic variants of VDBP may affect the absorption of vitamin D and cause variability in 25 (OH) D levels, which complicates the development of uniform recommendations for optimal prophylactic doses of vitamin D and necessitates additional research. The highest levels of 25 (OH) D were recorded in children with genotypes AA rs 4588 and TT rs 7041 of the VDBP gene, which showed high absorption when taking vitamin D supplements at a dose of 500 IU and even excessive concentrations of 25 (OH) D with long-term supplementation in higher dose.


Nutrients ◽  
2018 ◽  
Vol 10 (6) ◽  
pp. 680 ◽  
Author(s):  
Neil Brett ◽  
Paula Lavery ◽  
Sherry Agellon ◽  
Catherine Vanstone ◽  
Susan Goruk ◽  
...  

2016 ◽  
Vol 5 ◽  
Author(s):  
Anne Sidnell ◽  
Sandrine Pigat ◽  
Sigrid Gibson ◽  
Rosalyn O'Connor ◽  
Aileen Connolly ◽  
...  

AbstractNutrition in the second year is important as this is a period of rapid growth and development. Milk is a major food for young children and this analysis evaluated the impact of the type of milk consumed on nutrient intakes and nutritional status. Data from the Diet and Nutrition Survey of Infants and Young Children were used to investigate the intakes of key nutrients, and Fe and vitamin D status, of children aged 12–18 months, not breastfed, and consuming >400 g/d fortified milk (n 139) or >400 g/d of whole cows’ milk (n 404). Blood samples from eligible children for measurement of Hb (n 113), serum ferritin and plasma 25-hydroxyvitamin D (25(OH)D) concentrations (n 105) were available for approximately 20 % of children. Unpaired Mann–Whitney tests were used to compare nutrient intakes and status between consumers of fortified and cows’ milk. Mean daily total dietary intakes of Fe, Zn, vitamin A and vitamin D were significantly higher in the fortified milk group. Mean daily total dietary intakes of energy, protein, Ca, iodine, Na and saturated fat were significantly higher in the cows’ milk group. Hb was not different between groups. The fortified milk group had significantly higher serum ferritin (P = 0·049) and plasma 25(OH)D (P = 0·014). This analysis demonstrates significantly different nutrient intakes and status between infants consuming >400 g/d fortified milk v. those consuming >400 g/d whole cows’ milk. These results indicate that fortified milks can play a significant role in improving the quality of young children's diets in their second year of life.


2018 ◽  
Vol 64 (2) ◽  
pp. 99-105 ◽  
Author(s):  
Satoshi NAKANO ◽  
Mitsuyoshi SUZUKI ◽  
Kei MINOWA ◽  
Saeko HIRAI ◽  
Noriyuki TAKUBO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document